Shveta Suresh Motwani, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cisplatin | 7 | 2024 | 1662 | 2.270 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1972 | 2.150 |
Why?
|
Paraproteins | 1 | 2016 | 39 | 0.570 |
Why?
|
Fluid Shifts | 5 | 2014 | 19 | 0.490 |
Why?
|
Paraproteinemias | 1 | 2016 | 246 | 0.470 |
Why?
|
Kidney Glomerulus | 1 | 2016 | 697 | 0.460 |
Why?
|
Kidney Diseases | 3 | 2020 | 2149 | 0.400 |
Why?
|
Amyloidosis | 1 | 2016 | 795 | 0.350 |
Why?
|
Airway Resistance | 4 | 2014 | 404 | 0.350 |
Why?
|
Ascites | 2 | 2020 | 344 | 0.310 |
Why?
|
Hyponatremia | 2 | 2020 | 298 | 0.290 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2170 | 0.230 |
Why?
|
Sleep Apnea, Obstructive | 5 | 2014 | 1813 | 0.230 |
Why?
|
Kidney | 4 | 2023 | 7186 | 0.200 |
Why?
|
Neoplasms | 5 | 2023 | 21683 | 0.190 |
Why?
|
Kidney Tubules | 1 | 2023 | 488 | 0.190 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13695 | 0.190 |
Why?
|
Pharynx | 2 | 2013 | 413 | 0.190 |
Why?
|
Immunoglobulin Light Chains | 2 | 2020 | 277 | 0.170 |
Why?
|
Creatinine | 2 | 2024 | 1919 | 0.170 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2020 | 113 | 0.170 |
Why?
|
Kidney Function Tests | 1 | 2020 | 684 | 0.160 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 426 | 0.160 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2016 | 42 | 0.140 |
Why?
|
Cryoglobulinemia | 1 | 2016 | 87 | 0.140 |
Why?
|
Sleep Apnea Syndromes | 2 | 2016 | 944 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2208 | 0.130 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2016 | 86 | 0.130 |
Why?
|
Pleural Neoplasms | 1 | 2020 | 607 | 0.130 |
Why?
|
Drainage | 1 | 2020 | 1142 | 0.130 |
Why?
|
Thrombotic Microangiopathies | 1 | 2016 | 132 | 0.120 |
Why?
|
Sodium | 1 | 2020 | 1623 | 0.120 |
Why?
|
Glomerulonephritis | 1 | 2016 | 372 | 0.120 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2016 | 659 | 0.110 |
Why?
|
Body Water | 1 | 2014 | 343 | 0.110 |
Why?
|
Leg | 3 | 2014 | 1116 | 0.110 |
Why?
|
Immunomodulation | 1 | 2016 | 541 | 0.110 |
Why?
|
Sleep Apnea, Central | 1 | 2013 | 84 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2023 | 3086 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1620 | 0.100 |
Why?
|
Respiratory System | 1 | 2014 | 557 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1270 | 0.100 |
Why?
|
Body Fluids | 1 | 2012 | 319 | 0.100 |
Why?
|
Neck | 2 | 2012 | 697 | 0.090 |
Why?
|
Pressure | 1 | 2013 | 1203 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1378 | 0.090 |
Why?
|
Polysomnography | 5 | 2014 | 1776 | 0.090 |
Why?
|
Renal Dialysis | 3 | 2016 | 1786 | 0.090 |
Why?
|
Kidney Failure, Chronic | 2 | 2012 | 2538 | 0.090 |
Why?
|
Middle Aged | 15 | 2024 | 213383 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2021 | 2245 | 0.080 |
Why?
|
Humans | 24 | 2024 | 744343 | 0.080 |
Why?
|
Carbon Dioxide | 1 | 2013 | 1150 | 0.080 |
Why?
|
Edema | 1 | 2012 | 789 | 0.080 |
Why?
|
Apoptosis | 1 | 2023 | 9727 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3143 | 0.070 |
Why?
|
Water | 1 | 2012 | 1395 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4445 | 0.070 |
Why?
|
Risk | 1 | 2018 | 9687 | 0.070 |
Why?
|
Aged | 11 | 2023 | 163280 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4262 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4560 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13408 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5181 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2024 | 77449 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2624 | 0.050 |
Why?
|
Blood Pressure | 1 | 2016 | 8554 | 0.040 |
Why?
|
Adult | 9 | 2024 | 214055 | 0.040 |
Why?
|
Electric Impedance | 2 | 2014 | 729 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
Male | 15 | 2023 | 350118 | 0.040 |
Why?
|
Prognosis | 5 | 2020 | 29063 | 0.040 |
Why?
|
Risk Factors | 6 | 2024 | 72290 | 0.040 |
Why?
|
Water-Electrolyte Balance | 1 | 2020 | 346 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2014 | 2029 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57776 | 0.040 |
Why?
|
Nephritis, Interstitial | 1 | 2020 | 156 | 0.040 |
Why?
|
Heart Failure | 2 | 2013 | 10900 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8642 | 0.040 |
Why?
|
Female | 13 | 2023 | 380194 | 0.040 |
Why?
|
Hyperthermia, Induced | 1 | 2020 | 403 | 0.040 |
Why?
|
Hypertension | 1 | 2016 | 8480 | 0.030 |
Why?
|
Gravity Suits | 1 | 2014 | 12 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 40561 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2124 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 56430 | 0.030 |
Why?
|
Jugular Veins | 1 | 2014 | 204 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2020 | 1094 | 0.030 |
Why?
|
Partial Pressure | 1 | 2013 | 254 | 0.030 |
Why?
|
Adolescent | 2 | 2018 | 85781 | 0.030 |
Why?
|
Child | 1 | 2020 | 77709 | 0.030 |
Why?
|
Ontario | 1 | 2012 | 383 | 0.020 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2016 | 546 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2014 | 12026 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5300 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39050 | 0.020 |
Why?
|
Respiration | 1 | 2016 | 1653 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2886 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 23338 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9849 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Posture | 1 | 2011 | 958 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.020 |
Why?
|
Wakefulness | 1 | 2013 | 1245 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20129 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12788 | 0.020 |
Why?
|
Lower Extremity | 1 | 2012 | 1158 | 0.020 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5952 | 0.010 |
Why?
|
Sleep | 1 | 2016 | 4623 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11524 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10397 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 35421 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15540 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40075 | 0.010 |
Why?
|
Prospective Studies | 1 | 2012 | 53288 | 0.000 |
Why?
|
Animals | 1 | 2016 | 168757 | 0.000 |
Why?
|